1. Di Iorio BR, Aucella F, Stallone C, Bellizzi V, Thalassaemia Minor in Hemodialysis Study Group. Thalassaemia minor: national survey of uraemic patients under substitutive treatment [in Italian]. G Ital Nefrol. 2002;19:286–293.
2. Cheng IK, Lu HB, Wei DC, Cheng SW, Chang CY, Lee FC. Influence of thalassemia on the response to recombinant human erythropoietin in dialysis patients. Am J Nephrol. 1993;13:142–148.
3. Dore F, Bonfigly S, Gaviano E, Pardini S, Longinotti M. Serum transferrin receptor levels in patients with thallassemia intermedia during rHuEPO administration. Haematologica. 1996;81:37–39.
4. Voulgari PV, Chaidos A, Tzouvara E, et al. Antierythropoietin antibodies in thalassemia patients. Ann Hematol. 2004;83:22–27.
5. Locatelli F, Aljama P, Barany P, et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. SECTION II. Targets for anaemia treatment. Nephrol Dial Transplant. 2004;19(suppl. 2):ii6–ii15.